1. Home
  2. AMRX

as 12-18-2024 9:46am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Founded: 2002 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 2.5B IPO Year: N/A
Target Price: $10.00 AVG Volume (30 days): 1.1M
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.63 EPS Growth: N/A
52 Week Low/High: $5.01 - $9.48 Next Earning Date: 11-08-2024
Revenue: $2,680,420,000 Revenue Growth: 12.32%
Revenue Growth (this year): 17.86% Revenue Growth (next year): 3.90%

AMRX Daily Stock ML Predictions

Stock Insider Trading Activity of Amneal Pharmaceuticals Inc. (AMRX)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Kiely John AMRX Director Nov 22 '24 Sell $8.38 17,058 $142,946.04 267,175
Autor Deborah M. AMRX Director Nov 21 '24 Sell $8.38 40,000 $334,073.97 86,631
Daly Jason B. AMRX SVP, Chief Legal Officer Nov 21 '24 Sell $8.40 13,665 $114,786.00 0
Daly Jason B. AMRX SVP, Chief Legal Officer Nov 15 '24 Sell $8.61 43,657 $375,886.77 0

Share on Social Networks: